
Meet our Scientific Advisory Board: Interview with Gerd Maack
GeneralGerd Maack works at the German Environment Agency in the unit Environmental Risk Assessment of Pharmaceuticals. In this function he assesses the Environmental Risk Assessment of new pharmaceutical applications of Human and Veterinary Medicinal…

PREMIER holds its first meeting with the Scientific Advisory Board members.
GeneralThe Executive Committee (ExCom) members of PREMIER, formed by the Work Package (WP) Leads, met with the Scientific Advisory Board (SAB) for the first time in a virtual setting.
It was a very dynamic meeting with various break-out sessions…

PREMIER aims to work synergistically with the main EU initiatives promoting environmental protection
GeneralThe European Green week this year focuses on the EU ‘zero pollution ambition´ to promote a toxic-free environment. PREMIER aligns and contributes to the main European actions under the EU green deal which provides a legal framework for regulatory…

What are the needs of stakeholders regarding the environmental risk assessment of pharmaceuticals? Participate in our Survey!
GeneralThe survey "Stakeholder needs and requirements regarding the environmental risk assessment of pharmaceuticals" is now online until the 19 July 2021!!
If your work deals in some regard with pharmaceuticals in the environment, we would…

The innovative PREMIER database: creating a robust architecture to deliver consistent environmental data to the community
GeneralThe PREMIER project will deliver a novel database and digital assessment system (DAS) for characterising the environmental risks of medicines and making environmental data more visible and accessible to industry, academia, regulators and the…

PREMIER welcomes its Scientific Advisory Board
GeneralThe PREMIER project started on 1st Sep 2020 with the objective to achieve a more sustainable future by proactively managing the environmental impact of medicines. We are delighted to announce that we have recently formed our new Scientific…

World Water Day: Valuing water
GeneralClean surface water is the basis of safe drinking water, enjoyable recreational activities and a vibrant nature, rich in biodiversity. PREMIER contributes to safe and clean water through improving the environmental risk assessment of pharmaceuticals.
Because…

Meet our Scientific Advisory Board: Interview with John Jensen
GeneralJohn Jensen, PhD, Senior Scientist, Deputy Head of Department, Department of Bioscience, Aarhus University
What is your field of expertise?
Senior researcher within ecotoxicology and ecology with special interest in pharmaceuticals, having…

IMI funds a project to manage the environmental risks of medicines
GeneralThe Innovative Medicines Initiative (IMI) has approved a 9.7 million euro project to contribute to a sustainable future by proactively managing the environmental impact of medicines. Lead by Radboud University Nijmegen and the pharmaceutical…

European Initiative to minimise the environmental impact of medicines
General
The Prioritisation and Risk Evaluation of Medicines in the Environment (PREMIER) Innovative Medicines Initiative (IMI) project will design a novel information and assessment system for identifying and addressing the environmental risks of…



